Liraglutide Protects Neurite Outgrowth of Cortical Neurons Under Oxidative Stress though Activating the Wnt Pathway.
J Stroke Cerebrovasc Dis · 2018
Last updated 2026-05-28In lab tests on mouse brain cells under stress, the drug liraglutide improved cell survival and reduced cell death. It also helped the cells grow longer extensions, which are important for brain function, and this effect was weakened when a specific pathway (Wnt) was blocked.
AI summary of the abstract below.
| Journal | J Stroke Cerebrovasc Dis, 2018 |
|---|---|
| Citations | 13 |
| Relative citation ratio | 0.58 |
| NIH percentile | 33 |
| Molecules | liraglutide |
| Conditions studied | Alzheimers |
Abstract
BACKGROUND: Neurogenesis including neurite outgrowth is important for brain plasticity under physiological conditions and in brain repair after injury. Liraglutide has been found to have neuroprotective action in the risk of central nervous system disease. However, the effect and the potential mechanism of liraglutide-induced neurite outgrowth in primary cortical neurons under oxidative stress remain poorly documented.
METHODS: In the text, HO was used to mimic ischemia injury in primary cortical neurons. The viability and apoptosis of cell was assessed by Cell Counting Kit-8 and Hoechst 33342. Immunofluorescence method was used to examine the effect of liraglutide on neurite outgrowth in cortical neuron under HO condition. Then, the potential mechanisms involving the Wnt pathway were investigated. The expression of β-catenin, c-myc, and cyclin D1 was determined using quantitative real-time polymerase chain reaction and Western blot.
RESULTS: Liraglutide significantly increased the viability and alleviated the apoptosis rate of cortical neurons induced by HO. Next, liraglutide promoted neurite outgrowth, which could be partially inhibited by the Wnt pathway inhibitor Xav939. Besides, liraglutide induced an increase of β-catenin, c-myc, and cyclin D1 levels, which could also be blocked in the presence of Xav939.
CONCLUSIONS: These results illustrate that liraglutide exerts neurotrophin-like activity in cortical neurons under oxidative stress condition, partly through activating the Wnt pathway.
Verbatim abstract via PubMed 30042033 ↗
Related research
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
- Liraglutide and Renal Outcomes in Type 2 Diabetes.
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
- The Discovery and Development of Liraglutide and Semaglutide.